These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15605945)

  • 21. Blood pressure in Native Americans switched from celecoxib to rofecoxib.
    Fredy J; Diggins DA; Morrill GB
    Ann Pharmacother; 2005 May; 39(5):797-802. PubMed ID: 15797981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of rofecoxib withdrawal on cyclooxygenase-2 utilization among patients with and without cardiovascular risk.
    Thiebaud P; Patel BV; Nichol MB
    Value Health; 2006; 9(6):361-8. PubMed ID: 17076866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preemptive rofecoxib and dexamethasone for prevention of pain and trismus following third molar surgery *.
    Moore PA; Brar P; Smiga ER; Costello BJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Feb; 99(2):E1-7. PubMed ID: 15660075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical care expenditures under gatekeeper and point-of-service arrangements.
    Escarce JJ; Kapur K; Joyce GF; Van Vorst KA
    Health Serv Res; 2001 Dec; 36(6 Pt 1):1037-57. PubMed ID: 11775666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in physicians' practice of prescribing cyclooxygenase-2 inhibitor after market withdrawal of rofecoxib: a retrospective study of physician-patient pairs in Taiwan.
    Hsiao FY; Tsai YW; Huang WF
    Clin Ther; 2009 Nov; 31(11):2618-27. PubMed ID: 20110006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Satisfaction among soldiers with secondary medical services within military and civilian clinical settings.
    Goldberg A; Pliskin JS; Peterburg Y
    Mil Med; 2002 Aug; 167(8):634-8. PubMed ID: 12188232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind prospective comparison of rofecoxib vs ketorolac in reducing postoperative pain after arthroscopic knee surgery.
    Kim JT; Sherman O; Cuff G; Leibovits A; Wajda M; Bekker AY
    J Clin Anesth; 2005 Sep; 17(6):439-43. PubMed ID: 16171664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prescribing patterns of rofecoxib in the primary care setting: results of a French survey].
    Bannwarth B; Logeart I; Vergult G
    Rev Med Interne; 2004 Oct; 25(10):710-4. PubMed ID: 15471596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Assessment of the number of cardio- and cerebrovascular events due to rofecoxib (Vioxx) in Germany between 2001 and 2004].
    Sawicki PT; Bender R; Selke GW; Klauber J; Gutschmidt S
    Med Klin (Munich); 2006 Mar; 101(3):191-7. PubMed ID: 16648975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
    Liu SZ; Romeis JC
    Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The patient as a client: a model for evaluation of Israel Defense Forces.
    Zigdon A; Robinson A; Goldberg A
    Mil Med; 2004 Apr; 169(4):282-7. PubMed ID: 15132230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized controlled study comparing rofecoxib, diclofenac sodium, and placebo in post-bunionectomy pain.
    Desjardins PJ; Black PM; Daniels S; Bird SR; Fitzgerald BJ; Petruschke RA; Tershakovec A; Chang DJ
    Curr Med Res Opin; 2004 Oct; 20(10):1523-37. PubMed ID: 15462686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis.
    Maetzel A; Krahn M; Naglie G
    Arthritis Rheum; 2003 Jun; 49(3):283-92. PubMed ID: 12794781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outsourcing of primary care: satisfaction level in the Israeli Defense Forces.
    Magnezi R; Kedem R; Reuveni H
    Mil Med; 2004 May; 169(5):379-84. PubMed ID: 15186004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term and long-term tolerability of rofecoxib in patients with prior reactions to nonsteroidal anti-inflammatory drugs.
    Nettis E; Colanardi MC; Ferrannini A; Tursi A
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):29-33. PubMed ID: 15702812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with celecoxib and rofecoxib utilization.
    Rawson NS; Nourjah P; Grosser SC; Graham DJ
    Ann Pharmacother; 2005 Apr; 39(4):597-602. PubMed ID: 15755796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does perioperative administration of rofecoxib improve analgesia after spine, breast and orthopaedic surgery?
    Riest G; Peters J; Weiss M; Pospiech J; Hoffmann O; Neuhäuser M; Beiderlinden M; Eikermann M
    Eur J Anaesthesiol; 2006 Mar; 23(3):219-26. PubMed ID: 16430794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analgesic efficacy of the cyclooxygenase-inhibiting nitric oxide donor AZD3582 in postoperative dental pain: Comparison with naproxen and rofecoxib in two randomized, double-blind, placebo-controlled studies.
    Michael Hill C; Sindet-Pederson S; Seymour RA; Hawkesford JE; Coulthard P; Lamey PJ; Gerry Cowan C; Wickens M; Jeppsson L; Dean AD; Svensson O
    Clin Ther; 2006 Sep; 28(9):1279-95. PubMed ID: 17062301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the incidence rates of thromboembolic events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data.
    Layton D; Heeley E; Hughes K; Shakir SA
    Rheumatology (Oxford); 2003 Nov; 42(11):1342-53. PubMed ID: 12832706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilization of non-steroidal anti-inflammatory drugs in Quebec: adherence to the Canadian consensus on prescription guidelines.
    Moride Y; Ducruet T; Boivin JF; Lavoie F; Rochon S
    Can J Clin Pharmacol; 2005; 12(2):e201-11. PubMed ID: 15998959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.